Bayer Builds Cardiovascular Franchise With Possis Purchase

Bayer HealthCare will expand its cardiovascular device offerings by acquiring AngioJet thrombectomy system maker Possis Medical for $361 million under a deal announced Feb. 11

More from Archive

More from Medtech Insight